Tag: risk disclosures

risk disclosures

Regulatory/FDA

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

July 22, 2019 – Social science research conducted at the FDA’s Office of Prescription Drug Promotion (OPDP) is designed to investigate issues relevant to healthcare professional and consumer use of medical product information, to consider the audience’s perception and comprehension of that information, and to assess the accuracy and effectiveness of promotional messaging, according to […]

Read more